Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-15

Clinical Trial Update: Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen? [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether inhaled Fluticasone Propionate reduces the late allergic reaction when given after allergen exposure in patients with mild inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flovent (fluticasone propionate)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Mild Intermittent Asthma | Phase 4 | Status: COMPLETED | Results posted: 2015-05-15